Vascular Biogenics Ltd.

NasdaqCM:VBLT 주식 보고서

시가총액: US$12.1m

Vascular Biogenics 관리

관리 기준 확인 4/4

Vascular Biogenics CEO는 Dror Harats, Jan2001 에 임명되었습니다 의 임기는 22.75 년입니다. 총 연간 보상은 $ 887.62K, 40.3% 로 구성됩니다. 40.3% 급여 및 59.7% 보너스(회사 주식 및 옵션 포함). 는 $ 177.68K 가치에 해당하는 회사 주식의 1.47% 직접 소유합니다. 177.68K. 경영진과 이사회의 평균 재임 기간은 각각 17.8 년과 5.4 년입니다.

주요 정보

Dror Harats

최고 경영자

US$887.6k

총 보상

CEO 급여 비율40.3%
CEO 임기22.8yrs
CEO 소유권1.5%
경영진 평균 재임 기간17.8yrs
이사회 평균 재임 기간5.4yrs

최근 관리 업데이트

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Recent updates

VBL Therapeutics receives non-compliance letter from Nasdaq

Sep 01

VBL Therapeutics GAAP EPS of -$0.12

Aug 15

VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals

Jul 19

Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

May 18
Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump

Sep 03

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

Jan 28
How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

VBL Therapeutics expands the ovarian cancer trial in Europe

Dec 29

Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Dec 24
Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 19
Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

VBL Therapeutics EPS beats by $0.01, misses on revenue

Nov 16

CEO 보상 분석

Dror Harats 의 보수는 Vascular Biogenics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$25m

Dec 31 2022US$888kUS$357k

-US$32m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$35m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$1mUS$349k

-US$30m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$27m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020n/an/a

-US$24m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$889kUS$405k

-US$19m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$815kUS$375k

-US$20m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$12m

Dec 31 2017n/an/a

-US$10m

Sep 30 2017n/an/a

-US$21m

Jun 30 2017n/an/a

-US$18m

Mar 31 2017n/an/a

-US$16m

Dec 31 2016US$515kUS$406k

-US$16m

보상 대 시장: Dror 의 총 보상 ($USD 887.62K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 647.72K ).

보상과 수익: Dror 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Dror Harats (66 yo)

22.8yrs

테뉴어

US$887,624

보상

Prof. Dror Harats, MD, has been the Chief Executive Officer of Vascular Biogenics Ltd., since January 2001. Prof. Harats founded VBL in 2000 based on many years of research in Atherosclerosis, Vascular Bio...

리더십 팀

이름위치테뉴어보상소유권
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Samuel Backenroth
Chief Financial Officer2yrsUS$669.08k0.68%
$ 81.9k
Eyal Breitbart
Senior Vice President of Research & Operations17.8yrsUS$433.79k데이터 없음
Ayelet Horn
General Counsel23.8yrs데이터 없음데이터 없음
Erez Feige
Senior Vice President of Business Operations1.7yrsUS$374.71k데이터 없음

17.8yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: VBLT 의 관리팀은 노련하고 경험 (평균 재직 기간 17.8 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Ruth Alon
Independent Non-Executive Director13.6yrsUS$94.25k0%
$ 0
David Hastings
Independent Non-Executive Director5.8yrsUS$101.30k0%
$ 0
Ruth Arnon
Scientific Consultant & Member of Scientific Advisory Board2.3yrs데이터 없음데이터 없음
Marc Kozin
Independent Non-Executive Chairman3yrsUS$205.67k0.050%
$ 6.1k
Shmuel Ben-Zvi
Independent Non-Executive Director5.1yrsUS$96.88k0.077%
$ 9.4k
Patrick Wen
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Andrew Brenner
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Richard Penson
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Timothy Cloughesy
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Nicholas Butowski
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Kathleen Moore
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

5.4yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: VBLT 의 이사회는 경험(평균 재직 기간 5.4 년)으로 간주됩니다.